作者: Luis G. Melo , Alok S. Pachori , Massimiliano Gnecchi , Victor J. Dzau
DOI: 10.1016/J.MOLMED.2005.03.008
关键词:
摘要: Recent advances in understanding the molecular and cellular basis of cardiovascular diseases, together with availability tools for genetic manipulation system, offer possibilities new treatments. Gene therapies have demonstrated potential usefulness treating complex such as hypertension, atherosclerosis myocardial ischemia, various animal models. Some these experimental are now undergoing clinical evaluation patients disease. However, successful transition into mainstream practice awaits further improvements to vector platforms delivery documentation feasibility, safety efficacy through multi-center randomized trials.